Increased red blood cell polyamines in ALS and Parkinson's disease

Experimental Neurology

Volumn 177, Issue 2, 2002, Pages 515-520

  Gomes Trolin, C ^a   Nygren, I ^a   Aquilonius, S M ^a   Askmark, H ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ALS; PD; Polyamines; Red blood cell

Indexed keywords

POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMINE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; MALE; PARKINSON DISEASE; PRECURSOR; PRIORITY JOURNAL;

EID: 0036434881     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2002.7952     Document Type: Article

References (45)

1. Axerold, J., and R. Tomchick. 1958. Enzymatic O-methylation of adrenaline and other catechols. J. Biol. Chem. 233: 702-705.
2. Beal, M. F. 1998. Excitotoxicity and nitric oxide in PD pathogenesis. Ann. Neurol. 44 (Suppl 1): 110-114.
3. Benson, R., B. Crowell, B. Hill, K. Doonquah, and C. Charlton. 1993. The effects of L-Dopa on the activity of methionine adenosyltransferase: Relevance to L-Dopa therapy and tolerance. Neurochem. Res. 18: 325-330.
4. Bernstein, H.-G., and M. Müller. 1999. The cellular localization of the L-ornithine decarboxylase/polyamine system in normal and diseased central nervous system. Progress Neurobiol. 57: 485-505.
5. Betnér, I., and P. Földi. 1988. The FMOC-ADAM approach to amino acid analysis. LC-GC 6: 832-840.
6. Brooks, B. R. 1994. El Escorial World Foundation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J. Neurol. Sci. 124: 96 -107.
7. Cheng, H., C. Gomes-Trolin, S.-M. Aquilonious, A. Steinberg, C. Löfberg, J. Eklebon, and L. Oreland. 1997. Levels of L-Methionine S-Adenosyltransferase activity in erythrocytes and concentrations of S-Adenosylmethionine and S-Adenosylhomocysteine in whole blood of patients with Parkinson's disease. Exp. Neurol. 145: 580-585.
8. Chaudhuri, D., I. Choudhury, and M. Mukherjea, 1983. Ontogeny of polyamines in relation to nucleic acids in brain and spinal cord of the developing human fetus. Dev. Brain. Res. 10: 13-145.
9. Cohen, L. F., D. W. Lundgren, and P. M. Farrell. 1976. Distribution of spermidine and spermine in blood from cystic fibrosis patients and control subjects. Blood 48: 469-475.
10. Double A. 1999. The role of excitotoxicity in neurodegenerative disease: Implications for therapy. Pharmacol. Ther. 81: 163-221.
11. Einarsson, S., B. Josefsson, and S. Lagerkvist. 1983. Determination of amino acids with 9-fluorenylmethyl chloroformate and reversed-phase high-performance liquid chromatography. J. Chromatogr. 282: 609-618.
12. Ekker, M., T. L. Sourkes, and R. Gabor. 1988. Reduced amounts of S-Adenosylmethionine decarboxylase in the adrenal glands of rats following administration of piribedil or 2-deoxyglucose. Biochem. Pharmacol. 37: 3613-3618.
13. Elworthy, P., and E. Hitchcock. 1989. Red blood cell polyamines as a diagnostic indicator of glioma presence and recurrence. J. Neuro-Oncol. 7: 31-38.
14. Ferchmin, P. A., D. Pérez, and M. Biello. 2000. Spermine is neuroprotective against anoxia and N-methyl-D-aspartate in hippocampal slices. Brain Res. 859: 273-279.
15. Gerlach, M., H. Desser, M. B. H. Youdin, and P. Riederer. 1996. New horizonts in molecular mechanisms underlying PD and in our understanding of the neuroprotective effects of selegiline. J. Neural Transm. 148 (Suppl): 7-21.
16. Gilad, G. M., and V. H. Gilad. 1992. Polyamines in neurotrauma. Ubiquotous molecule in search of a function. Biochem. Pharmacol. 44: 401-407.
17. Gilad, G. M., and V. H. Gilad. 1999. Novel polyamine derivatives as neuroprotective agents. J. Pharmacol Exp. Therap. 291: 39 -43.
18. Goodenough, S., M. Davidson, K. Grahame et al. 2000. Cell death and immunohistochemistry of p53, c-Fos and c-Jun after spermine injection into the rat striatum. Exp. Brain Res. 131: 126-134.
19. Henley, C. M., C. Muszynski, L. Cherian, and C. S. Robertson. 1996. Activation of ornithine decarboxylase and accumulation of putrescine after traumatic brain injury. J. Neurotraum. 13: 487-496.
20. Hoehn, M. W., and M. D. Yahr. 1967. Parkinsonism: Onset, progression, and mortality. Neurology 17: 427-445.
21. Hughes, A. J., S. E. Daniel, L. Kilford, and A. J. Lees. 1992. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatr. 55: 181-184.
22. Igarashi, K., and K. Kashiwagi. 2000. Polyamines: Mysterious modulators of cellular functions. Biochem. Biophys. Res. Commun. 271: 559 -564.
23. Kaminska, A. M., L. Z. Stern, and D. H. Russel. 1981. Altered muscle polyamine levels in human neuromuscular diseases. Ann. Neurol. 9: 605-607.
24. Louvel, E., J. Hugom, and A. Doble. 1997. Therapeutic advances in amyotrophic lateral sclerosis. Trends Pharmacol. Sci. 18: 196-203.
25. Mautes, A. E. M., W. Paschen, G. Röhn, and A. C. Nacimiento. 1999. Changes in ornithine decarboxylase activity and pu-trescine concentrations after spinal cord compression injury in the rat. Neurosci. Lett. 264: 153-156.
26. Meldrum, B. S. 2000. Glutamate as a neurotransmitter in the brain: Review of physiology and pathology. J. Nutr. 130: 1007S-1015S.
27. Morrison, L. D., L. Becker, L. C. Ang, and S. J. Kish. 1995. Polyamines in human brain: Regional distribution and influ-ence of aging. J. Neurochem. 65: 636-642.
28. Moulinoux, J.-P., M. Le Calve, V. Quemener, and G. Quash. 1984. In vitro studies on the entry of polyamines into normal red blood cells. Biochemie 66: 385-393.
29. Moulinoux, J.-Ph, V. Quemener, M. Le Calve, M. Chatel, and F. Darcel. 1984. Polyamines in human brain tumours. J. Neuro-Oncol. 2: 153-158.
30. Moulinoux, J., V. Quemener, J. The ́ron, R. Havouis, F. Darcel, Y. Guegan, P. Courtheoux, and M. Chatel. 1988. Erythrocyte polyamines: Their diagnostic and therapeutic importance in human neuro-oncology. Adv. Exp. Med. Biol. 250: 353-363
31. Norris, F. H., P. R. Calanchini, R. J. Fallat, S. Panchari, and B. Jewett. 1974. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 24: 721-728.
32. Oosthuyse, B., L. Moons, E. Storkebaum, H. Beck et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nature Genet. 28: 131-138.
33. Pegg, A. E., and P. McCann. 1982. Polyamine metabolism and function: A review. Am. J. Physiol. 243: C212-221.
34. Persson, L., and E. Rosengren. 1987. Dopaminergic regulation of polyamine synthesis in the rat pituitary gland. Mol. Cell. Endocrinol. 51: 219 -225.
35. Russel, D. H. 1983. Clinical relevance of polyamines. Crit. Rev. Clin. Lab. Sci. 18: 261-311.
36. Shaw, P. J., and P. G. Ince. 1997. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J. Neurol. 244 (Suppl. 2): S3-S14.
37. Sparapani, M., R. DallÓlio, O. Gandolfi, E. Ciani, and A. Contestabile. 1997. Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells. Exp. Neurol. 148: 157-166.
38. Szathmáry, I., L. Selmeci, A. Szobor, and J. Molnár. 1994. Altered polyamine levels in skeletal muscle of patients with myasthenia gravis. Clin. Neuropathol. 13: 181-184.
39. Tabor, C. W., and H. Tabor. 1984. Polyamines. Annu. Rev. Biochem. 53: 749-790.
40. Tadolini, B., G. Hakim, G. Orlandini, and A. Casti. 1986. Intracellular location of polyamines associated to red blood cells. Biochem. Biophys. Res. Commun. 134: 1365-1371.
41. Van den Berg, G. A., A. W. Kingma, and F. A. J. Muskiet. 1987. Determination of polyamines in human erythrocytes by capillary gas chromatography with nitrogen-phosphorus detection. J. Chromatogr. 415: 27-34.
42. Vivó, M., N. de Vera, R. Cortés, G. Mengod et al. 2001. Polyamines in the basal ganglia of human brain. Influence of aging and degenerative movement disorders. Neurosci. Lett. 304: 107-111
43. Williams, K. 1997. Modulation and block of ion channels: A new biology of polyamines. Cell. Signal 9: 1-13.
44. Wurtman, R. J., C. M. Rose, S. Matthysse, J. Stephenson, and R. Baldessarini. 1970. L-Dihydroxyphenylalanine: Effect on S-Adenosylmethionine in brain. Science 169: 395-397.
45. Youdim, M. B. H., and P. Riederer. 1993. The relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in Parkinson's disease. Movement Disorders 8 (Suppl. 1): S8-S13.